Abstract
The risk of lymphoma may be increased by about fourfold in patients with inflammatory bowel disease treated with thiopurines. The increased risk could be a result of the medications, the severity of the underlying disease, or a combination of the two.
Cite
CITATION STYLE
APA
McGovern, D. P. B., & Jewell, D. P. (2005, August). Risks and benefits of azathioprine therapy. Gut. https://doi.org/10.1136/gut.2004.053231
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free